Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
about
Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality?Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancerChemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancerNatural terpenes prevent mitochondrial dysfunction, oxidative stress and release of apoptotic proteins during nimesulide-hepatotoxicity in ratsAnti-cancer efficacy of silybin derivatives -- a structure-activity relationshipHepatoprotective effects of litchi (Litchi chinensis) procyanidin A2 on carbon tetrachloride-induced liver injury in ICR miceSilibinin inhibits ICAM-1 expression via regulation of N-linked and O-linked glycosylation in ARPE-19 cells.Pathogenesis of alcoholic liver disease: role of oxidative metabolism.Potent hepatoprotective effect in CCl(4)-induced hepatic injury in mice of phloroacetophenone from Myrcia multiflora.Brazilian Bidens pilosa Linné yields fraction containing quercetin-derived flavonoid with free radical scavenger activity and hepatoprotective effects.Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis.Effect of silymarin in diabetes mellitus patients with liver diseases.The effect of silymarin on hepatic regeneration after partial hepatectomy: is silymarin effective in hepatic regeneration?Potent natural products and herbal medicines for treating liver fibrosisCytochrome P450 enzyme mediated herbal drug interactions (Part 1)Silymarin Accelerates Liver Regeneration after Partial HepatectomyEffect of subclinical, clinical and supraclinical doses of calcium channel blockers on models of drug-induced hepatotoxicity in rats.Hepatoprotective activity of ethanolic extract of Salix subserrata against CCl4-induced chronic hepatotoxicity in ratsConsumer satisfaction and efficacy of the hangover cure after-effect(©).Antioxidant, Hepatoprotective Potential and Chemical Profiling of Propolis Ethanolic Extract from Kashmir Himalaya Region Using UHPLC-DAD-QToF-MS.Efficacy of Boesenbergia rotunda Treatment against Thioacetamide-Induced Liver Cirrhosis in a Rat Model.The protective effect of silybin against lasalocid cytotoxic exposure on chicken and rat cell linesHepatoprotective and antioxidant effects of saponarin, isolated from Gypsophila trichotoma Wend. on paracetamol-induced liver damage in rats.Mechanism of Hepatoprotective Effect of Boesenbergia rotunda in Thioacetamide-Induced Liver Damage in Rats.Protective Effects of Silymarin, Alone or in Combination with Chlorogenic Acid and/or Melatonin, Against Carbon Tetrachloride-induced Hepatotoxicity.Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial.Role of serotonergic system on modulation of depressogenic-like effects of silymarine.Teratogenic effects of silymarin on mouse fetuses.Population pharmacokinetics of sirolimus in de novo Chinese adult renal transplant patients.Aqueous extract of Gracilaria tenuistipitata suppresses LPS-induced NF-κB and MAPK activation in RAW 264.7 and rat peritoneal macrophages and exerts hepatoprotective effects on carbon tetrachloride-treated rat.Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells.Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failureHepatoprotective Effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in Combination: A Possible Synergy.Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspectiveThe strategies to control prostate cancer by chemoprevention approaches.Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.Protective effects of goldenseal (Hydrastis canadensis L.) on acetaminophen-induced hepatotoxicity through inhibition of CYP2E1 in rats.
P2860
Q26765790-DB2CECE5-CCB3-4503-B205-F7F7E7052346Q26995304-D1D3E591-5B63-4C29-9A5F-47E2E03CFC08Q26998615-ADE570C7-95F7-4566-B3F5-E3403C91CB79Q28482088-FC0F1650-5D2C-4658-8982-23C0F63AE44AQ28489104-744E4E2C-9533-4619-8551-16324ED4037AQ33744444-AD670325-E99D-4095-B064-FC362C6B7490Q33852271-92D552E2-2A6E-4E3B-973E-3C4A6A6D7D37Q34750539-FC715349-AF5C-4A55-B025-CE8699387564Q34764175-1C83B28D-78DA-4B2E-B7C3-470541DFBD11Q34849929-AF94BF49-3214-492C-9B9A-B7AADF673B76Q35126099-398C32E8-4BA1-417A-8564-924ED4A8E6C2Q35411480-A1B25935-8CCF-4859-AE65-F4C06751DC99Q35480818-03419B0A-3A63-4E90-98E7-E7EFF159D83DQ35494410-05D561F3-F19A-4985-A7C2-6629268F1AD5Q35725540-CC478B9D-9E59-4846-BA4E-E2D23B346BA1Q35962716-CB6D9127-BC8C-402C-9C6B-2FAE99D14303Q36003065-89CC15AA-3266-4B95-8872-98257723A941Q36090295-C959898F-A17B-47C9-B202-21F53097C689Q36125008-056C243F-B03A-4E01-96F5-AC8A7CBEA5AFQ36204077-84C4870B-6747-4A7E-92C3-A656315FBDC6Q36228792-0AB52116-9AF8-4F4C-B582-4BC85AEAE048Q36665001-B4FCC66F-6FCA-417B-80EF-F66A6ED8E87BQ37002757-E9DF9E97-E760-442E-949C-802E2413E5EFQ37111252-31FB6C11-BFD9-4738-8562-385ADADDD619Q37149008-73709136-7743-4D6F-86C7-6BD76FC78FFFQ37178168-C764E9BE-F566-454F-B08C-BEA0BA9FC2ADQ37268154-01615BAA-1EB7-459F-9272-55F90F58BD58Q37314378-40F35EA9-25D9-4149-8244-66D6C3689876Q37321421-5BB9B815-B5D7-4489-A5BE-B0CE470D0E0BQ37520860-0316610E-F82D-4C8E-9A7B-E1322A138D21Q37585138-ADED151D-96A8-49A2-883C-881BE267BE60Q37586474-706CA5FF-BD50-41C5-A95D-0F92B4BBB7B5Q37591742-7C89E2D3-DFCB-40FA-AC04-94CA477D5608Q37602609-B50C2095-FD4D-44D6-AD9F-21B0B3DE66E8Q37699893-DCA0177B-06D9-4CDB-986E-377A37257623Q37730653-FE43DA7A-3373-4D71-8C14-041A9C43B053Q38175776-CF001BF4-1F38-42F1-A41F-20B63347879CQ39016642-2BBDCA73-1D95-47F2-A12A-F2C3CA3847C4Q39547376-CB9EAAFA-78D9-48AB-9899-39929EFB13EFQ40107250-9C98C5F4-E98C-46D5-9E5B-F2FCD25B5B43
P2860
Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hepatoprotective herbal drug, ...... macology to clinical medicine.
@ast
Hepatoprotective herbal drug, ...... macology to clinical medicine.
@en
Hepatoprotective herbal drug, ...... macology to clinical medicine.
@nl
type
label
Hepatoprotective herbal drug, ...... macology to clinical medicine.
@ast
Hepatoprotective herbal drug, ...... macology to clinical medicine.
@en
Hepatoprotective herbal drug, ...... macology to clinical medicine.
@nl
prefLabel
Hepatoprotective herbal drug, ...... macology to clinical medicine.
@ast
Hepatoprotective herbal drug, ...... macology to clinical medicine.
@en
Hepatoprotective herbal drug, ...... macology to clinical medicine.
@nl
P1476
Hepatoprotective herbal drug, ...... macology to clinical medicine.
@en
P2093
P304
P407
P577
2006-11-01T00:00:00Z